Regeneron Announces FDA Has Extended Approval Of Evkeeza To Children 5-11 With HoFH
Regeneron Announces FDA Has Extended Approval Of Evkeeza To Children 5-11 With HoFH
再生龍宣布 FDA 已通過 HOFH 將埃夫基埃薩擴大對 5-11 歲兒童的批准
Regeneron Announces FDA Has Extended Approval Of Evkeeza To Children 5-11 With HoFH
再生龍宣布 FDA 已通過 HOFH 將埃夫基埃薩擴大對 5-11 歲兒童的批准
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。